MedTrace Logo

Meditoxin® Treatment in Patients With Cervical Dystonia

NCT03232320 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2019-03-27

No results posted yet for this study

Summary

To determine the efficacy and safety of Meditoxin in subjects with cervical dystonia compared with placebo (normal saline)

Conditions

  • Dystonia
  • Dystonic Disorder

Interventions

DRUG

Meditoxin

Meditoxin (Botulinum toxin type A)

DRUG

Placebo

Placebo (Normal saline)

Sponsors & Collaborators

  • Medy-Tox

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-06
Primary Completion
2018-10-31
Completion
2018-11-05

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03232320 on ClinicalTrials.gov